1 / 8

Nonalcoholic Steatohepatitis Treatment Market – Global Industry Outlook, and Analysis, 2018-2026

The most widely used treatment for NASH is to eliminate potential causes and risk factors such as weight loss and treatment for hyperglycemia or dyslipidemia.

saairaj
Télécharger la présentation

Nonalcoholic Steatohepatitis Treatment Market – Global Industry Outlook, and Analysis, 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nonalcoholic Steatohepatitis Treatment Market - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026

  2. REPORT DESCRIPTION Nonalcoholic Steatohepatitis Treatment Market – Overview Nonalcoholic steatohepatitis (NASH) is a form of nonalcoholic fatty liver disease (NAFLD) in which a person have hepatitis and inflammation of the liver, and can cause liver damage. NASH can lead to complications, such as cirrhosis and liver cancer. Patients with NASH have high chance of mortality due to liver-related causes such as liver failure. Lifestyle modification, including change in diet and exercise, is the basic therapy recommended for nonalcoholic fatty liver disease. However, in some cases lifestyle modification is difficult to achieve and to sustain, and therefore required other treatments including medicine. Currently available drugs for the treatment of NAFLD were historically been given for other indications. For instance, Orlistat, a gut lipase inhibitor, is indicated for decrease in the dietary fats absorption. According to the National Center for Biotechnology Information (NCBI) 2017 study, Orlistat has been approved for treatment of obesity and is available over the counter in the U.S. for weight loss. Orlistat-mediated weight loss is related with reduction in hepatic steatosis.

  3. REPORT DESCRIPTION Nonalcoholic Steatohepatitis Treatment Market Taxonomy: By Drug: Cenicriviroc Elafibranor Ocaliva (Obeticholic Acid) Selonsertib By Distribution Channel: Hospital Pharmacy Retail Pharmacy Online Pharmacy Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2279

  4. REPORT DESCRIPTION Nonalcoholic Steatohepatitis Treatment Market – Key Players AstraZeneca Plc., Conatus Pharmaceuticals, Enzo Biochem, Inc., GENFIT SA, Galmed Pharmaceuticals Ltd., Gilead Science, Immuron Ltd., Intercepts Pharmaceuticals, Novo Nordisk, Raptor Pharmaceutical Corporation, and Tobira Therapeutics, Inc.           Read More @ https://www.coherentmarketinsights.com/market-insight/nonalcoholic-steatohepatitis-treatment-market-2279

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH SYNDICATED RESEARCH INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICA L OUR CLIENTS  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools.

  7. ABOUT US RESEARCH SOLUTIONS KEY STATS GLOBAL REPORTS FEASIBILITY STUDIES 100 Insights Published Per Year + 150+ COUNT RY ANALYS IS CUSTOMIZED SOLUTIONS CONSUL T PROJECT S Consulting Projects Till Date 125+ SURVEY RESEAR CH EXCEL FORECAST DATABASE COMPETITIV E ASSESSMEN T Clients Worldwide Per Year 110+ TECHNOLOG Y SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702

More Related